UroGen Pharma (URGN): TD Bank group discloses 3.37M shares, 6.9% beneficial stake

Rhea-AI Filing Summary

The Toronto-Dominion Bank and TD Securities Inc. report beneficial ownership of 3,371,263 ordinary shares of UroGen Pharma Ltd., representing 6.9% of the outstanding class of ordinary shares, par value NIS 0.01 per share.

The Toronto-Dominion Bank has sole voting and dispositive power over 3,269,957 shares, while TD Securities Inc. has sole voting and dispositive power over 101,306 shares. TD Securities Inc. is wholly owned by The Toronto-Dominion Bank. The Toronto-Dominion Bank may be deemed to hold an indirect interest in TD Securities Inc.’s shares through this ownership but expressly disclaims beneficial ownership of those shares except to the extent of its pecuniary interest. The reporting persons also state that nothing in the disclosure should be construed as them acting as part of a group with any other person regarding UroGen Pharma securities.

Key Figures

Beneficial ownership: 3,371,263 shares Percent of class: 6.9% TD Bank sole voting and dispositive power: 3,269,957 shares +2 more

5 metrics

Beneficial ownership 3,371,263 shares Total UroGen Pharma ordinary shares beneficially owned by TD Bank and TD Securities

Percent of class 6.9% Portion of UroGen Pharma ordinary share class reported as beneficially owned

TD Bank sole voting and dispositive power 3,269,957 shares Ordinary shares over which The Toronto-Dominion Bank has sole voting and dispositive power

TD Securities sole voting and dispositive power 101,306 shares Ordinary shares over which TD Securities Inc. has sole voting and dispositive power

CUSIP M96088105 CUSIP for UroGen Pharma ordinary shares, par value NIS 0.01 per share

Key Terms

beneficially owned, sole voting power, dispositive power, Schedule 13(d), +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 3,371,263 TD Bank has the sole power"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole Voting Power 3,269,957.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"Sole Dispositive Power 3,269,957.00 8 | Shared Dispositive Power 0.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Schedule 13(d) regulatory

"for the purposes of Section 13(d) of the US Securities Exchange Act"

Rule 13d-1(k) regulatory

"in accordance with Rule 13d-1(k) , as amended."

FAQ

How many UroGen Pharma (URGN) shares are reported as beneficially owned by TD Bank and TD Securities?

TD Bank and TD Securities together report 3,371,263 ordinary shares of UroGen Pharma beneficially owned, which includes 3,269,957 shares for TD Bank and 101,306 shares for TD Securities Inc.

What percentage of UroGen Pharma (URGN) does The Toronto-Dominion Bank group report owning?

They report beneficial ownership of 6.9% of the outstanding class of UroGen Pharma ordinary shares. This percentage reflects the combined holdings attributed to The Toronto-Dominion Bank and TD Securities Inc. as described in the ownership disclosure.

How are voting and dispositive powers over UroGen Pharma (URGN) shares divided between TD Bank and TD Securities?

The Toronto-Dominion Bank has sole voting and dispositive power over 3,269,957 shares, while TD Securities Inc. has sole voting and dispositive power over 101,306 shares. Neither entity reports any shared voting or shared dispositive power.

Does The Toronto-Dominion Bank consider itself the owner of UroGen Pharma (URGN) shares held by TD Securities?

The Toronto-Dominion Bank states it may be deemed to hold an indirect interest in TD Securities’ UroGen shares due to its ownership of TD Securities, but it disclaims beneficial ownership except to the extent of its pecuniary interest.

Are The Toronto-Dominion Bank and TD Securities acting as part of a group regarding UroGen Pharma (URGN) stock?

The reporting persons state that neither their disclosure nor any related actions should be construed as them acting as a group with any other person for acquiring, holding, or disposing of UroGen Pharma securities.

Who signed the UroGen Pharma (URGN) beneficial ownership disclosure for TD Bank and TD Securities?

The disclosure is signed by Christina Petrou, Executive Vice President & Chief Operating Officer of The Toronto-Dominion Bank, and Jason Chen, Senior Vice President – Global Operations and Business Services of TD Securities Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:11 PM Accepted by SEC EDGAR 08/12/2026 - 04:10 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

UroGen Pharma Ltd.

(Name of Issuer)

Ordinary Shares, par value NIS 0.01 per share

(Title of Class of Securities)

M96088105

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): M96088105

1

Names of Reporting Persons

The Toronto-Dominion Bank

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,269,957.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,269,957.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,269,957.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.7 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

CUSIP Number(s): M96088105

1

Names of Reporting Persons

TD SECURITIES INC.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 101,306.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 101,306.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

101,306.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.2 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

Item 1.
(a)	Name of issuer: UroGen Pharma Ltd.
(b)	Address of issuer's principal executive offices: 9 HA'TA'ASIYA ST, RA'ANANA, ISRAEL 4365007
Item 2.
(a)	Name of person filing: The Toronto-Dominion Bank TD SECURITIES INC.
(b)	Address or principal business office or, if none, residence: The principal office address of The Toronto-Dominion Bank ("TD Bank"): 66 Wellington Street West 12th Floor TD Tower Toronto, Ontario, Canada M5K 1A2 The principal office address of TD Securities Inc. ("TDSI"): 55 King Street West TD Tower 12th Floor Toronto, Ontario, Canada M5K 1A2
(c)	Citizenship: The Toronto-Dominion Bank - CANADA (FEDERAL LEVEL) TD SECURITIES INC. - ONTARIO, CANADA
(d)	Title of class of securities: Ordinary Shares, par value NIS 0.01 per share
(e)	CUSIP No.: M96088105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	TD Bank - Bank TDSI - Broker Dealer
Item 4.	Ownership
(a)	Amount beneficially owned: 3,371,263 TD Bank has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 3,269,957 of these shares and TDSI has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 101,306 of these shares. This schedule is jointly filed by TD Bank and TDSI. TD Bank is the sole owner of TDSI. TD Bank may be deemed to hold an indirect interest in the shares reported herein by TDSI by virtue of its ownership of TDSI. TD Bank disclaims ownership of the shares reported herein by TDSI except to the extent of its pecuniary interest therein. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
(b)	Percent of class: 6.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The Toronto-Dominion Bank - 3,269,957 TD SECURITIES INC. - 101,306
	(ii) Shared power to vote or to direct the vote: The Toronto-Dominion Bank - 0 TD SECURITIES INC. - 0
	(iii) Sole power to dispose or to direct the disposition of: The Toronto-Dominion Bank - 3,269,957 TD SECURITIES INC. - 101,306
	(iv) Shared power to dispose or to direct the disposition of: The Toronto-Dominion Bank - 0 TD SECURITIES INC. - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Toronto-Dominion Bank

Signature:	Christina Petrou
Name/Title:	Christina Petrou / Executive Vice President & Chief Operating Officer
Date:	08/12/2026

TD SECURITIES INC.

Signature:	Jason Chen
Name/Title:	Jason Chen / Senior Vice President - Global Operations and Business Services
Date:	08/12/2026

Exhibit Information

Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the ordinary shares of UroGen Pharma Ltd. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: August 12, 2026 THE TORONTO-DOMINION BANK By: /s/ Christina Petrou Title: Executive Vice President & Chief Operating Officer TD SECURITIES INC. By: /s/ Jason Chen Title: Senior Vice President - Global Operations and Business Services